M F Para

1.8k total citations
34 papers, 1.5k citations indexed

About

M F Para is a scholar working on Infectious Diseases, Virology and Endocrinology. According to data from OpenAlex, M F Para has authored 34 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 12 papers in Virology and 10 papers in Endocrinology. Recurrent topics in M F Para's work include HIV Research and Treatment (12 papers), Legionella and Acanthamoeba research (10 papers) and HIV/AIDS Research and Interventions (9 papers). M F Para is often cited by papers focused on HIV Research and Treatment (12 papers), Legionella and Acanthamoeba research (10 papers) and HIV/AIDS Research and Interventions (9 papers). M F Para collaborates with scholars based in United States, Poland and Israel. M F Para's co-authors include Patricia G. Spear, J F Plouffe, Joseph F. Plouffe, Albert Miller, Roderick R. Turner, Anthony L. Cunningham, T. C. Merigan, Lynn C. Goldstein, Caroline C. Whitacre and Robert J. Fass and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Psychiatry and Applied and Environmental Microbiology.

In The Last Decade

M F Para

34 papers receiving 1.3k citations

Peers

Countries citing papers authored by M F Para

Since Specialization

Citations

This map shows the geographic impact of M F Para's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M F Para with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M F Para more than expected).

Fields of papers citing papers by M F Para

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M F Para. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M F Para. The network helps show where M F Para may publish in the future.

Co-authorship network of co-authors of M F Para

This figure shows the co-authorship network connecting the top 25 collaborators of M F Para. A scholar is included among the top collaborators of M F Para based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M F Para. M F Para is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vesatolimod (GS-9620) is safe and pharmacodynamically active in HIV-infected individuals 2019 ·Journal of Virus Eradication ·Sharon A. Riddler, M F Para, Constance A. Benson, A. Scott Mills, Moti Ramgopal, E DeJesus, Cynthia Brinson, Joshua C. Cyktor, (unknown), (unknown), Brian Doehle, Svetlana Markova, Heena Patel, Hiba Graham, Joseph Hesselgesser, Romas Geleziunas, Diana M. Brainard, Scott McCallister, Devi SenGupta	6
2	Virologic and CD4 ⁺ Cell Responses to New Nucleoside Regimens: Switching to Stavudine or Adding Lamivudine after Prolonged Zidovudine Treatment of Human Immunodeficiency Virus Infection 2000 ·AIDS Research and Human Retroviruses ·David Katzenstein, H. Hughes, Mary Albrecht, S. Hammer, M F Para, Robert L. Murphy, Hernán Valdez, Richard Haubrich, Saou-Hsing Liou	11
3	Effect of Lamivudine in HIV-Infected Persons with Prior Exposure to Zidovudine/Didanosine or Zidovudine/Zalcitabine 2000 ·AIDS Research and Human Retroviruses ·Mary Albrecht, Michael D. Hughes, Shu-Hao Liou, David Katzenstein, Robert L. Murphy, Henry H. Balfour, M F Para, Hernán Valdez, Scott M. Hammer	2
4	Delavirdine Susceptibilities and Associated Reverse Transcriptase Mutations in Human Immunodeficiency Virus Type 1 Isolates from Patients in a Phase I/II Trial of Delavirdine Monotherapy (ACTG 260) 2000 ·Antimicrobial Agents and Chemotherapy ·Lisa M. Demeter, Robert W. Shafer, (unknown), Jeanne Holden‐Wiltse, Margaret A. Fischl, William W. Freimuth, M F Para, Richard C. Reichman	67
5	Phase I/II Study of the Toxicity, Pharmacokinetics, and Activity of the HIV Protease Inhibitor SC-52151 1997 ·Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Margaret A. Fischl, Douglas D. Richman, Charles Flexner, M F Para, Richard Haubrich, Aziz Karim, Patrick Yeramian, Jeanne Holden‐Wiltse, (unknown)	27
6	Phase I Study of Atevirdine, a Nonnucleoside Reverse Transcriptase Inhibitor, in Combination with Zidovudine for Human Immunodeficiency Virus Type 1 Infection 1995 ·The Journal of Infectious Diseases ·Richard C. Reichman, Gene D. Morse, Lisa M. Demeter, Lionel Resnick, Yiannis Bassiakos, Margaret A. Fischl, M F Para, William G. Powderly, John M. Leedom, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	14
7	Foscarnet for suppression of human immunodeficiency virus replication 1994 ·Antimicrobial Agents and Chemotherapy ·Courtney V. Fletcher, Ann C. Collier, Frank S. Rhame, (unknown), M F Para, (unknown), (unknown), Henry H. Balfour	28
8	Magnetic resonance imaging of white matter lesions in HIV infection 1992 ·Journal of Neuropsychiatry ·Robert A. Bornstein, Donald W. Chakeres, Martha Brogan, H.A. Nasrallah, Robert J. Fass, M F Para, Caroline C. Whitacre	20
9	Rate of CD4 Decline and Neuropsychological Performance in HIV Infection 1991 ·Archives of Neurology ·R. A. Bornstein, Henry A. Nasrallah, M F Para, Robert J. Fass, Caroline C. Whitacre, R. Rice	45
10	Comparison of Molecular Methods for Subtyping Patients and Epidemiologically Linked Environmental Isolates of Legionella pneumophila 1988 ·The Journal of Infectious Diseases ·Jason E. Stout, J Joly, M F Para, Joseph F. Plouffe, Carol A. Ciesielski, Martin J. Blaser, Victor L. Yu	62
11	Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions 1985 ·Journal of Virology ·M F Para, (unknown), A. Gwendolyn Noble, Patricia G. Spear	102
12	Serum bactericidal activity against Legionella pneumophila 1985 ·Journal of Clinical Microbiology ·Joseph F. Plouffe, M F Para, Kathryn A. Fuller	18
13	Aerosols containing Legionella pneumophila generated by shower heads and hot-water faucets 1985 ·Applied and Environmental Microbiology ·(unknown), J F Plouffe, M F Para, (unknown)	151
14	Evolution of recurrent herpes simplex lesions. An immunohistologic study. 1985 ·Journal of Clinical Investigation ·Anthony L. Cunningham, Roderick R. Turner, Albert Miller, M F Para, T. C. Merigan	189
15	Serological differences in Legionella pneumophila infections 1984 ·Journal of Clinical Microbiology ·Joseph F. Plouffe, (unknown), M F Para, Kathe A. Kelly	4
16	Production of monoclonal antibodies to Legionella pneumophila serogroups 1 and 6 1983 ·Journal of Clinical Microbiology ·M F Para, J F Plouffe	36
17	Plasmid profiles of clinical and environmental isolates of Legionella pneumophila serogroup 1 1983 ·Journal of Clinical Microbiology ·William E. Maher, Joseph F. Plouffe, M F Para	35
18	Glycoprotein gE of herpes simplex virus type 1: effects of anti-gE on virion infectivity and on virus-induced fc-binding receptors 1982 ·Journal of Virology ·M F Para, (unknown), Patricia G. Spear	90
19	Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein 1982 ·Journal of Virology ·M F Para, Lynn C. Goldstein, Patricia G. Spear	101
20	Correlation of the absolute configuration of phosphorus thio-acids by nuclear magnetic resonance spectroscopy 1970 ·Journal of the Chemical Society D Chemical Communications ·M. Mikołajczyk, M F Para, Andrzej Ejchart, Janusz Jurczak	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact